The Streptococcus pyogenes capsule is required for adhesion of bacteria to virus-infected alveolar epithelial cells and lethal bacterial-viral superinfection

Infection and Immunity

Volumn 72, Issue 10, 2004, Pages 6068-6075

  Okamoto, Shigefumi ^a   Kawabata, Shigetada ^a,b   Terao, Yutaka ^a   Fujitaka, Hideaki ^a   Okuno, Yoshinobu ^c   Hamada, Shigeyuki ^a  

^a OSAKA UNIVERSITY   (Japan)

^b JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

^c OSAKA PREFECTURAL INSTITUTE OF PUBLIC HEALTH   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL PROTEIN; EXOTOXIN; PROTEIN MGA; STREPTOCOCCUS PYROGENIC EXOTOXIN B; STREPTOLYSIN O; STREPTOLYSIN S; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL MEMBRANE; BACTERIUM ADHERENCE; CONTROLLED STUDY; HISTOPATHOLOGY; INFLUENZA VIRUS A; LETHALITY; LUNG ALVEOLUS EPITHELIUM; MORTALITY; MOUSE; MUTANT; NONHUMAN; PRIORITY JOURNAL; PROTEIN SYNTHESIS INHIBITION; STREPTOCOCCUS GROUP A; STREPTOCOCCUS INFECTION; STREPTOCOCCUS PYOGENES; SUPERINFECTION; VIRUS INFECTION; WILD TYPE;

ANIMALS; BACTERIAL ADHESION; BACTERIAL CAPSULES; BACTERIAL PROTEINS; CELL LINE; EPITHELIAL CELLS; FEMALE; GENES, BACTERIAL; HUMANS; INFLUENZA A VIRUS; INFLUENZA, HUMAN; MICE; MICE, INBRED BALB C; MUTAGENESIS; MUTATION; N-ACETYLNEURAMINIC ACID; STREPTOCOCCAL INFECTIONS; STREPTOCOCCUS PYOGENES; SUPERINFECTION; SURVIVAL RATE; VIRULENCE;

EID: 4644339358     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/IAI.72.10.6068-6075.2004     Document Type: Article

References (51)

1. Alouf, J. 1980. Streptococcal toxins (streptolysin O, streptolysin S, erythrogenic toxin). Pharmacol. Ther. 11:661-717.
2. Anders, E. M., C. A. Hartley, and D. C. Jackson. 1990. Bovine and mouse β inhibitor of influenza A viruses are mannose-binding lectins. Proc. Natl. Acad. Sci. USA 87:4485-4489.
3. Ashbaugh, C. D., H. B. Warren, V. J. Carey, and M. R. Wessels. 1998. Molecular analysis of the role of the group A streptococcal cysteine protease, hyaluronic acid capsule, and M protein in a murine model of human invasive soft-tissue infection. J. Clin. Investig. 102:550-560.
4. Baxter, F., and J. McChesney. 2000. Severe group A streptococcal infection and streptococcal toxic shock syndrome. Can. J. Anaesth. 47:1129-1140.
5. Brammer, T. L., H. S. Izurieta, K. Fukuda, L. M. Schmeltz, H. L. Regnery, H. E. Hall, and N. J. Cox. 2000. Surveillance for influenza-United States, 1994-95, 1995-96, and 1996-97 seasons. Morb. Mortal. Wkly. Rep. CDC Surveill. Summ. 49:13-28.
6. Bullough, P. A., F. M. Hughson, J. J. Skehel, and D. C. Wiley. 1994. Structure of influenza hemagglutinin at the pH of membrane fusion. Nature 371:37-43.
7. Chaussee, M. S., D. Ajdic, and J. J. Ferretti. 1999. The rgg gene of Streptococcus pyogenes NZ131 positively influences extracellular SPE B production. Infect. Immun. 67:1715-1722.
8. Chernomordik, L. V., V. A. Frolov, E. Leikina, P Bronk, and J. Zimmerberg. 1998. The pathway of membrane fusion catalyzed by influenza hemagglutinin: restriction of lipids, hemifusion, and lipidic fusion pore formation. J. Cell Biol. 140:1369-1382.
9. Courtney, H. S., J. B. Dale, and D. L. Hasty. 1996. Differential effects of streptococcal fibronectin-binding protein, FBP54, on adhesion of group A streptococci to human buccal cells and HEp-2 tissue culture cells. Infect. Immun. 64:2415-2419.
10. Cunningham, M. W. 2000. Pathogenesis of group A streptococcal infections. Clin. Microbiol. Rev. 13:470-511.
11. Cywes, C., I. Stamenkovis, and M. R. Wessels. 2000. CD44 as a receptor for colonization of pharynx by group A Streptococcus. J. Clin. Investig. 106:995-1002.
12. Demers, B., A. E. Simor, H. Vellend, P. M. Schlievert, S. Byrne, F. Jamieson, S. Walmsley, and D. E. Low. 1993. Severe invasive group A streptococcal infections in Ontario, Canada: 1987-1991. Clin. Infect. Dis. 16:792-800.
13. Francis, T. E., and M. V. de Torregrosa. 1945. Combined infection of mice with H. influenzae and influenza virus by the intranasal route. J. Infect. Dis. 76:70-77.
14. Gryllos, I., C. Cywes, M. H. Shearer, M. Cary, R. C. Kennedy, and M. R. Wessels. 2001. Regulation of capsule gene expression by group A Streptococcus during pharyngeal colonization and invasive infection. Mol. Microbiol. 42:61-74.
15. Hakansson, A., A. Kidd, G. Wadell, H. Sabharwal, and C. Svanborg. 1994. Adenovirus infection enhances in vitro adherence of Streptococcus pneumoniae. Infect. Immun. 62:2707-2714.
16. Harford, C. G., M. R. Smith, and W. B. Wood. 1946. Sulfonamide chemotherapy of combined infection with influenza virus and bacteria. J. Exp. Med. 83:505-518.
17. Hernandez, L. D., L. R. Hoffman, T. G. Wolfsberg, and J. M. White. 1996. Virus-cell and cell-cell fusion. Annu. Rev. Cell. Dev. Biol. 12:627-661.
18. Hosaka, Y., A. Ikeura, Y. Harada, K. Kuroda, H. Hamayasu, T. Suzuki, K. Yamada Y. Kawase, and Y. Suzuki. 2000. Binding of influenza type A viruses to group B Streptococcus and haemagglutination by virus-bound bacteria. J. Electron Microsc. 49:765-773.
19. Husmann, L. K., D.-L. Yung, S. K. Hollingshead, and J. R. Scott. 1997. Role of putative virulence factors of Streptococcus pyogenes in mouse model of long-term throat colonization and pneumonia. Infect. Immun. 65:1422-1430.
20. Jadoun, J., O. Eyal, and S. Sela. 2002. Role of CsrR, hyaluronic acid, and SpeB in the internalization of Streptococcus pyogenes M type 3 strain by epithelial cells. Infect. Immun. 70:462-469.
21. Jadoun, J., and S. Sela. 2000. Mutation in csrR global regulator reduces Streptococcus pyogenes internalization. Microb. Pathog. 29:311-317.
22. Jones, W. T., J. H. Menna, and D. E. Wennerstrom. 1983. Lethal synergism induced in mice by influenza type A virus and type Ia group B streptococci. Infect. Immun. 41:618-623.
23. Kaul, R., A. McGeer, D. E. Low, K. Green, and B. Schwartz. 1997. Population-based surveillance for group A streptococcal necrotizing fasciitis: clinical features, prognostic indications, and microbiologic analysis of seventy-seven cases. Am. J. Med. 103:18-24.
24. Kawabata, S., H. Kuwata, I. Nakagawa, S. Morimatsu, K. Sano, and S. Hamada. 1999. Capsular hyaluronic acid of group A streptococci hampers their invasion into human pharyngeal epithelial cells. Microb. Pathog. 27:71-80.
25. LeVine, A. M., V. Koeningknecht, and J. M. Stark. 2001. Decreased pulmonary clearance of S. pneumoniae following influenza A infection in mice. J. Virol. Methods 94:173-186.
26. Limbago, B., V. Penumalli, B. Weinrick, and J. R. Scott. 2000. Role of streptolysin O in a mouse model of invasive group A streptococcal diseases. Infect. Immun. 68:6384-6390.
27. McCullers, J. A., and J. E. Rehg. 2002. Lethal synergism between influenza virus and Streptococcuspneumoniae: characterization of a mouse model and the role of platelet-activating factor receptor. J. Infect. Dis. 186:341-350.
28. Musher, D. M., R. J. Hamill, C. E. Wright, J. E. Clarridge, and C. M. Ashton. 1996. Trends in bacteremic infection due to Streptococcus pyogenes (group A Streptococcus), 1986-1995. Emerg. Infect. Dis. 2:54-56.
29. Nakagawa, I., M. Nakata, S. Kawabata, and S. Hamada. 2001. Cytochrome c-mediated caspase-9 activation triggers apoptosis in Streptococcus pyogenes infected epithelial cells. Cell. Microbiol. 3:395-405.
30. Nakashima, K., S. Ichiyama, Y. Iinuma, Y. Hasegawa, M. Ohta, K. Ooe, Y. Shimizu, H. Igarashl, T. Mural, and K. Shimokata. 1997. A clinical and bacteriologic investigation of invasive streptococcal infections in Japan on the basis of serotypes, toxin production and genomic DNA fingerprints. Clin. Infect. Dis. 25:260-266.
31. Okada, N., A. P. Pentland, P. Falk, and M. G. Caparon. 1994. M protein and protein F act as important determinants of cell-specific tropism of Streptococcus pyogenes in skin tissue. J. Clin. Investig. 94:965-977.
32. Okamoto, S., S. Kawabata, I. Nakagawa, Y. Okuno, T. Goto, K. Sano, and S. Hamada. 2003. Influenza A virus-infected hosts boost invasive type of Streptococcus pyogenes infection in mice. J. Virol. 77:4104-4112.
33. Okamoto, S., S. Kawabata, I. Nakagawa, and S. Hamada. 2001. Administration of superantigens protects mice from lethal Listeria monocytogenes infection by enhancing cytotoxic T cells. Infect. Immun. 69:6633-6642.
34. Okuno, Y., Y. Isegawa, F. Sasao, and S. Ueda. 1993. A common neutralizing epitope conserved between the hemagglutinins of influenza A virus H1 and H2 strains. J. Virol. 67:2552-2558.
35. Reid, S. D., N. P. Hoe, L. M. Smoot, and J. M Musser. 2001. Group A Streptococcus: allelic variation, population genetics, and host-pathogen interactions. J. Clin. Investig. 107:393-399.
36. Ryan, P. A., V. Pancholi, and V. A. Fischetti. 2001. Group A streptococci bind to mucin and human pharyngeal cells through sialic acid-containing receptors. Infect. Immun. 69:7402-7412.
37. Sanford, B. A., A. Shelokov, and M. A. Ramsay. 1978. Bacterial adherence to virus-infected cells: a cell culture model of bacterial superinfection. J. Infect. Dis. 137:176-181.
38. Schranger, H. M., S. Alberti, C. Cywes, G. J. Dougherty, and M. R. Wessels. 1998. Hyaluronic acid capsule modulates M protein-mediated adherence and acts as a ligand for attachment of group A Streptococcus to CD44 on human keratinocytes. J. Clin. Investig. 101:1708-1716.
39. Schranger, H. M., J. G. Rheinwald, and M. R. Wessels. 1996. Hyaluronic acid capsule and the role of streptococcal entry into keratinocytes in invasive skin infection. J. Clin. Investig. 98:1954-1958.
40. Sierig, G., C. Cywes, M. R. Wessels, and C. D. Ashbaugh. 2003. Cytotoxic effects of streptolysin O and streptolysin S enhance the virulence of poorly encapsulated group A streptococci. Infect. Immun. 71:446-455.
41. , Svensson, N., S. Oberg, B. Henriques, S. Holm, G. Kallenius, V. Romanus, and J. Giesecke. 2000. Invasive group A streptococcal infections in Sweden in 1994 and 1995: epidemiology and clinical spectrum. Scand. J. Infect. Dis. 32:609-614.
42. Switalski, L. M., P. Speziale, M. Hook, T. Wadstrome, and R. Timpl. 1984. Binding of Streptococcus pyogenes to laminin. J. Biol. Chem. 259:3734-3738.
43. Tao, L., D. J. LeBlanc, and J. J. Ferretti. 1992. Novel streptococcal integration shuttle vectors for gene cloning and inactivation. Gene 120:105-110.
44. Taubenberger, J. K., A. H. Reid, and T. G. Fanning. 2000. The 1918 influenza virus: a killer comes into view. Virology 274:241-245.
45. Terao, Y., S. Kawabata, E. Kunitomo, J. Murakami, I. Nakagawa, and S. Hamada. 2001. Fba, a novel fibronectin-binding protein from Streptococcus pyogenes, promotes bacterial entry into epithelial cells, and the fba gene is positively transcribed under the Mga regulator. Mol. Microbiol. 42:75-86.
46. Terao, Y., S. Kawabata, E. Kunitomo, I. Nakagawa, and S. Hamada. 2002. Novel laminin-binding protein of Streptococcus pyogenes, Lbp, is involved in adhesion to epithelial cells. Infect. Immun. 70:993-997.
47. Terao, Y., S. Kawabata, M. Nakata, I. Nakagawa, and S. Hamada. 2002. Molecular characterization of a novel fibronectin-binding protein of Streptococcus pyogenes strains isolated from toxic shock-like syndrome patients. J. Biol. Chem. 277:47428-47435.
48. Warren, L. 1959. The thiobarbituric acid assay of sialic acid. J. Biol. Chem. 234:1971-1975.
49. Watanabe, T., S. Watanabe, G. Neumann, H. Kida, and Y. Kawaoka. 2002. Immunogenicity and protective efficacy of replication-incompetent influenza virus-like particles. J. Virol. 76:767-773.
50. Wessels, M. R., R. F. Haft, L. M. Heggen, and C. E. Rubens. 1992. Identification of a genetic locus essential for capsule sialylation in type III group B streptococci. Infect. Immun. 60:392-400.
51. Wessels, M. R., A. E. Moses, J. B. Goldberg, and T. J. DiCesare. 1994. Hyaluronic acid capsule is a virulence factor for mucoid group A streptococci. Proc. Natl. Acad. Sci. USA 91:12238-12242.